2025 年 5 月 10 日医麦客新闻 eMedClub News近日,阿斯利康在美国马里兰州罗克维尔投资 3 亿美元(约人民币 21.65 亿元)新建的细胞治疗生产基正式开业。阿斯利康全球运营执行副总裁帕姆·程(Pam Cheng)在 5 月 5 日该细胞生产基地的正式开业仪式上表示,“我们深知我们所做工作的重要性,因为生命和健康危在旦夕。”该中心一旦投入运营,将采用新型 CAR-T 细胞疗法...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.